Caldwell Trust’s Ionis Pharmaceuticals IONS Stock Holding History

Caldwell Trust’s Portfolio IONS Stock Details IONS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-4,000	Closed	-$177K	–	738
2022 Q3	$177K	Hold	4,000	–	–	0.03%	287
2022 Q2	$148K	Hold	4,000	–	–	0.02%	314
2022 Q1	$148K	Hold	4,000	–	–	0.02%	316
2021 Q4	$122K	Hold	4,000	–	–	0.01%	348
2021 Q3	$134K	Hold	4,000	–	–	0.02%	326
2021 Q2	$160K	Hold	4,000	–	–	0.02%	305
2021 Q1	$180K	Hold	4,000	–	–	0.03%	286
2020 Q4	$226K	Hold	4,000	–	–	0.03%	239
2020 Q3	$190K	Hold	4,000	–	–	0.03%	246
2020 Q2	$236K	Hold	4,000	–	–	0.04%	228
2020 Q1	$189K	Hold	4,000	–	–	0.04%	244
2019 Q4	$242K	Buy	+4,000	New	+$238K	0.04%	246

Other funds holding IONS

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.75B AUM 68.58% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TBC

Tweedy, Browne Co Stamford, Connecticut $1.32B AUM 32.9% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

Caldwell Trust's IONS Position: Q4 2022 in Review

Caldwell Trust sold out of Ionis Pharmaceuticals (IONS) in Q4 2022, closing a stake of 4,000 shares — an estimated $177K sold.

Caldwell Trust first reported a position in IONS in Q4 2019 and held it in 12 quarters. The position peaked at $242K in Q4 2019. 339 funds tracked by Wall St. Rank hold IONS as of Q4 2022.

Caldwell Trust reported no remaining Ionis Pharmaceuticals position as of Q4 2022 after selling out during the quarter.
Caldwell Trust sold 4,000 Ionis Pharmaceuticals shares in Q4 2022, an estimated $177K.
Caldwell Trust first reported a position in Ionis Pharmaceuticals in Q4 2019 and held it in 12 quarters.
Caldwell Trust's Ionis Pharmaceuticals position peaked at $242K in Q4 2019.
339 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q4 2022.

Based on Caldwell Trust's 13F filing for Q4 2022, filed 1 Oct 2025.